Torrid market for copycat weight loss drugs could be short-lived

  • 📰 NPR
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 63%

ایران اخبار اخبار

ایران آخرین اخبار,ایران سرفصلها

Cheaper versions of Wegovy and Zepbound touted on social media could be fleeting. Copies are legal now because the brand-name drugs are in short supply. But the drugmakers are boosting production.

iframe src="https://www.npr.org/player/embed/nx-s1-5033186/nx-s1-4106eb68-5dc7-44df-b6c2-0d069cac1558" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">Off-brand weight loss drugs containing the same active ingredients as Wegovy and Zepbound seem to be everywhere. Ads for the much cheaper alternatives are popping up on Instagram, in the subway and on TV.

Typically, compounded drugs are made for patients who aren’t served by existing FDA-approved medicines. For example, if someone needed a drug but was allergic to its preservative, a compounding pharmacist could prepare a version without that preservative., compounding pharmacies are usually not allowed to prepare what is “essentially a copy” of an existing FDA approved drug. But there’s an exception.

For larger compounding organizations called outsourcing facilities, they wouldn’t be able to make copies anymore. For smaller ones, they wouldn’t be able to make copies more than four times in one month.

این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

 /  🏆 96. in İR
 

از نظر شما متشکرم. نظر شما پس از بررسی منتشر خواهد شد.

ایران آخرین اخبار, ایران سرفصلها

Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.

Drug Companies Have a Sneaky Idea to Get Insurance to Pay for Drugs Like ZepboundScience and Technology News and Videos
منبع: futurism - 🏆 85. / 68 ادامه مطلب »